EUVIMEDEUVIMED entdecken
Kommentar

Nonsense variant readthrough therapy for epidermolysis bullosa

Martin Laimer

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae137 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Martin Laimer. Beteiligte Einrichtung: Department of Dermatology and Allergology and EB House Austria, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria. Hauptthemen laut MEDLINE: Codon, Nonsense, Epidermolysis Bullosa. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Codon, NonsenseEpidermolysis BullosaFemaleHumansMaleCollagen Type VIIGenetic Therapy

Substanzen

Codon, NonsenseCOL7A1 protein, humanCollagen Type VII

Autor:innen und Institutionen

  • Department of Dermatology and Allergology and EB House Austria, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.

Zitieren

APA

Laimer, M. (2024). Nonsense variant readthrough therapy for epidermolysis bullosa. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae137

Vancouver

Laimer M. Nonsense variant readthrough therapy for epidermolysis bullosa. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae137

BibTeX
@article{Laimer2024,
  author = {Laimer, Martin},
  title = {Nonsense variant readthrough therapy for epidermolysis bullosa},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae137}
}
Kostenlos starten →